Neumora Therapeutics Inc (NASDAQ:NMRA) has a beta value of 2.91 and has seen 0.69 million shares traded in the recent trading session. The company, currently valued at $117.69M, closed the recent trade at $0.73 per share which meant it gained $0.03 on the day or 3.21% during that session. The NMRA stock price is -2254.79% off its 52-week high price of $17.19 and 15.07% above the 52-week low of $0.62. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.92 million shares traded. The 3-month trading volume is 1.49 million shares.
The consensus among analysts is that Neumora Therapeutics Inc (NMRA) is Buy stock at the moment, with a recommendation rating of 2.44. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 3 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight.
Neumora Therapeutics Inc (NASDAQ:NMRA) trade information
Sporting 3.21% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the NMRA stock price touched $0.73 or saw a rise of 9.07%. Year-to-date, Neumora Therapeutics Inc shares have moved -93.14%, while the 5-day performance has seen it change 10.91%. Over the past 30 days, the shares of Neumora Therapeutics Inc (NASDAQ:NMRA) have changed -39.37%. Short interest in the company has seen 12.83 million shares shorted with days to cover at 9.83.
Wall Street analysts have a consensus price target for the stock at $3, which means that the shares’ value could jump 75.67% from the levels at last check today.. The projected low price target is $2.0 while the price target rests at a high of $4.0. In that case, then, we find that the latest price level in today’s session is -447.95% off the targeted high while a plunge would see the stock gain -173.97% from the levels at last check today..
Neumora Therapeutics Inc (NMRA) estimates and forecasts
The company’s shares have lost -95.59% over the past 6 months.
Earnings growth for 2025 is a modest 4.37% while over the next 5 years, the company’s earnings are expected to increase by 8.30%.
NMRA Dividends
Neumora Therapeutics Inc is expected to release its next earnings report on 2025-Mar-02 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Neumora Therapeutics Inc (NASDAQ:NMRA)’s Major holders
Insiders own 27.52% of the company shares, while shares held by institutions stand at 69.82% with a share float percentage of 96.34%. Investors are also buoyed by the number of investors in a company, with Neumora Therapeutics Inc having a total of 182.0 institutions that hold shares in the company. The top two institutional holders are FMR LLC with over 8.62 million shares worth more than $84.76 million. As of 2024-06-30, FMR LLC held 5.4235% of shares outstanding.
The other major institutional holder is SOFTBANK GROUP CORP., with the holding of over 7.65 million shares as of 2024-06-30. The firm’s total holdings are worth over $75.17 million and represent 4.8099% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . As of Dec 31, 2024 , the former fund manager holds about 1.44% shares in the company for having 2.32 shares of worth $1.72 million while later fund manager owns 2.21 shares of worth $1.64 million as of Mar 31, 2025 , which makes it owner of about 1.36% of company’s outstanding stock.
